Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amphastar Pharmaceuticals (AMPH) Exchange Rate Effect (2016 - 2025)

Historic Exchange Rate Effect for Amphastar Pharmaceuticals (AMPH) over the last 12 years, with Q3 2025 value amounting to -$41000.0.

  • Amphastar Pharmaceuticals' Exchange Rate Effect rose 3492.06% to -$41000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $208000.0, marking a year-over-year increase of 14988.01%. This contributed to the annual value of -$190000.0 for FY2024, which is 3262.41% up from last year.
  • According to the latest figures from Q3 2025, Amphastar Pharmaceuticals' Exchange Rate Effect is -$41000.0, which was up 3492.06% from $142000.0 recorded in Q2 2025.
  • Over the past 5 years, Amphastar Pharmaceuticals' Exchange Rate Effect peaked at $142000.0 during Q2 2025, and registered a low of -$238000.0 during Q4 2023.
  • Moreover, its 5-year median value for Exchange Rate Effect was -$38000.0 (2023), whereas its average is -$36631.6.
  • Its Exchange Rate Effect has fluctuated over the past 5 years, first crashed by 135263.16% in 2023, then surged by 84736.84% in 2025.
  • Over the past 5 years, Amphastar Pharmaceuticals' Exchange Rate Effect (Quarter) stood at -$48000.0 in 2021, then soared by 139.58% to $19000.0 in 2022, then tumbled by 1352.63% to -$238000.0 in 2023, then surged by 95.38% to -$11000.0 in 2024, then plummeted by 272.73% to -$41000.0 in 2025.
  • Its Exchange Rate Effect was -$41000.0 in Q3 2025, compared to $142000.0 in Q2 2025 and $118000.0 in Q1 2025.